COMMERCIAL STRATEGIES FOR THE ORIGINATOR AND BIOSIMILARS MARKETPLACE

The Economics of Biosimilars: Improving Market Access and Sustainable Pricing Across Europe

December 2, 2022 11:30am

  • Evaluating the clinical pipeline by company, indication and phase
    • Analyzing the market share for biosimilars in various regions
    • Target drugs with highest spending
    • Current market dynamics and considerations for biosimilar adoption
    • Comparing the European Union biosimilar experience
  • Considering the implications of insurers placing biosimilars on “primary tiers” and what that means for the future
  • Incentivizing providers to adopt biosimilars